Abstract
We conducted this study to isolate novel anti-hyperlipidemic agents derived from natural marine products. To accomplish this, we investigated the effects of ethanolic (EtOH) extracts of Ecklonia stolonifera and its phlorotannin constituents, eckol and dieckol, on serum lipid levels in rats with hyperlipidemia that was induced by a high-cholesterol diet or poloxamer 407. Treatment with the EtOH extracts of E. stolonifera and its phlorotannin-rich ethyl acetate (EtOAc) and n-butanol (n-BuOH) fractions induced a significant reduction in triglycerides (TG), total cholesterol (TC), and low-density lipoprotein-cholesterol (LDL-C) levels, as well as a significant increase in the high-density lipoprotein-cholesterol (HDLC) level in hyperlipidemic rats. However, treatment with the water (H2O) fraction did not exert any significant effects on the serum levels of hyperlipidemic rats. In addition, eckol and dieckol isolated from the active EtOAc fraction induced a significant reduction in serum TG, TC, and LDL-C levels, as well as in the atherogenic index (A.I.). Furthermore, treatment with dieckol induced a greater decrease in the serum TG, TC, and LDL-C levels of hyperlipidemic rats than eckol or lovastatin, as well as an increase in the serum HDL-C levels. Taken together, these results suggest that phlorotannins such as eckol and dieckol have the potential for use for the prevention of hyperlipidemic atherosclerosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn, M. J., Yoon, K. D., Kim, C. Y., Min, S. Y., Kim, Y. U., Kim, H. J., Kim, J. H., Shin, C. G., Lee, C. K., Kim. T. G., Kim, S. H., Huh, H., and Kim, J. W., Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts. J. Appl. Phycol., 14, 325–329 (2002).
Ara, J., Sultana, V., Qasim, R., and Ahmad, V. U., Hypolipidemic activity of seaweed from Karachi Coast. Phytother. Res., 16, 479–483 (2002).
Berliner, J. A. and Heinecks, J. W., The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. Med., 20, 707 (1996).
Choi, J. S., Yokozawa, T., and Oura, H., Antihyperlipidemic effect of flavonoids from Prunus davidiana. J. Nat. Prod., 54, 218–224 (1991).
Cogger, V. C., Warren, A., Fraser, R., Nqu, M., McLean, A. J., and Le Couteur, D. G., Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp. Gerontol., 38, 1101–1107 (2003).
Dallinga-Thie, G. M., Berk-Planken, II, Bootsma, A. H., and Jansen, H., Diabetes atorvastatin lipid intervention (DALI) Study Group, Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides. Diabetes Care, 27, 1358–1364 (2004).
De Bono, D. P. and Boon, N. A., Diseases of the cardiovascular system. In: Edwards, C. R. W., and Bouchier, I. A. D. (Eds.). Davidson’s principles and practice of medicine. ELBS Churchill Livingstone, Edinburgh, pp. 249–340 (1992).
Elwood, J. C., Nash, D. T., and Streeten, D. H., Effect of highchromium brewer’s yeast on human serum lipids. J. Am. Coll. Nutr., 1, 263–274 (1982).
Feussner, G., HMG-CoA reductase inhibitors. Curr. Opin. Lipidiol., 5, 59–60 (1994).
Fki, I., Bouaziz, M., Sahnoun, Z., and Sayadi, S., Hypocholesterolemic effects of phenolic-rich extracts of Chemlali olive cultivar in rats fed a cholesterol-rich diet. Bioorg. Med. Chem., 13, 5362–5370 (2005).
Grundy, S. M., Summary of the second report of the National Cholesterol Education Program (NCEP) export panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA., 269, 3015–3023 (1993).
Isley, W. L., Miles, J. M., Parrerson, B. W., and Harris, W. S., The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus. J. Lipid Res., 47, 193–200 (2006).
John K. S., Kathiravan, M. K., Somani, R. S., and Shishoo, C. J., The biology and chemistry of hyperlipidemia. Bioorg. Med. Chem., 15, 4674–4699 (2005).
Johnston, T. P. and Palmer, W. K., Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl CoA reductase in rats. J. Cardiovasc. Pharmacol., 29, 580–585 (1997).
Jung, H. A., Hyun, S. K., Kim, H. R., and Choi, J. S., Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fisheries Sci., 72, 1292–1299 (2006).
Kang, H. S., Chung, H. Y., Jung, J. H., Son, B. W., and Choi, J. S., A new phlorotannin from the brown alga Ecklonia stolonifera. Chem. Pharm. Bull., 51, 1012–1014 (2003).
Kang, H. S., Chung, H. Y., Kim, J. Y., Son, B. W., Jung, H. A., and Choi, J. S., Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch. Pharm. Res., 27, 194–198 (2004).
Kim, J. M., Seong, N. S., and Lee, Y. J., The effects of jwa kum-wham and soo ryeon-whan on the hyperlipidemia in rats. Korean J. Herbology, 20, 91–102 (2001).
Kim, Y. C., An, R. B., Yoon, N. Y., Nam, T. J., and Choi, J. S., Hepatoprotective constituents of the edible brown alga Ecklonia stolonifera on tacrine-induced cytotoxicity in Hep G2 cell. Arch. Pharm. Res., 28, 1376–1380 (2005).
Kim, Y. M., Han, C. K., Bang, S. J., and Park, J. H., Effect of laminaran from Eisenia bicyclis on serum lipid in rats fed high cholesterol diet. J. Kor. Soc. Food Sci. Nutr., 35, 841–846 (2006).
Kimura, Y., Watanabe, K., and Okuda, H., Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats. J. Ethnopharmacol., 54, 47–54 (1996).
Libby, P., Aikawa, M., and Schinbeck, U., Cholesterol and atherosclerosis. Biochim. Biophys. Acta., 1529, 299–309 (2000).
McKenney, J. M., Pharmacotherapy of dyslipidemia. Cardiovasc. Drugs Ther., 15, 413–422 (2001).
Megalli, S., Aktan, F., Davies, N. M., and Roufogalis, B. D., Phytopreventative anti-hyperlipidemic effects of Gynostemma pentaphyllum in rats. J. Pharm. Pharm. Sci., 8, 507–515 (2005).
Michanek, G., Seaweed resources for pharmaceutical uses. In: Hoppe, H. A., Levring, T., and Tanaka, Y. (Eds.). Marine Algae in Pharmaceutical Science. Walter de Gruyter, Berlin, New York, pp. 303–342 (1979).
Moral, D. W., Hessler, J. R., and Chisolm, G. M., Low density lipoprotein cytotoxicity induced by free radical peroxydation of lipid. J. Lipid Research, 24, 1070–1076 (1983).
Navab, M., Berliner, J. A., Watson A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., Edwards, P. A., and Fogelman, A. M., The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 george lyman duff memorial lecture. Arterioscler. Thromb. Vasc. Biol., 16, 839–842 (1996).
Nigon, F., Serfaty-Lacrosniere, C., Beucler, I., Beucler, I., Chauvois, D., Neveu, C., Giral, P., Chapman, M. J., and Bruckert, E., Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment. Clin. Chem. Lab. Med., 39, 634–640 (2001).
O’Keefe Jr. J. M., Lavie Jr. C. J., and McCallister, B. D., Insight into the pathogenesis and prevention of coronary artery disease. May. Clinic Proceeding, 70, 69–79 (1995).
Oliveros, L. B., Videla, A. M., Ramirez, D. C., and Gimenez, M. S., Dietary fat saturation produces lipid modifications in peritoneal macrophage of mouse. J. Nutr. Biochem., 14, 370–377 (2003).
Park, C. S., Hwang, E. K., Lee, S. J., Roh, K. W., and Sohn, C. H., Age of growth of Ecklonia stolonifera Okamura in Pusan bay, Korea. Bull. Korean Fish. Soc., 27, 390–396 (1994).
Pengzhan, Y., Ning, L., Xiguang, L., Gefei, Z., Quanbin, Z., and Pengcheng, L., Antihyperlipidemic effects of different molecular weight sulfated polysaccharides from Ulva pertusa (Chlorophyta). Pharmacol. Res., 48, 543–549 (2003).
Raymond, J., Metcalfe, A., Salazkin, I., and Schwarz, A., Temporary vascular occlusion with poloxamer 407. Biomaterials, 25, 3983–3989 (2004).
Ricci, E. J., Lunardi, L. D., Nauclares, D. M., and Marchetti, J. M., Sustained release of lidocaine from poloxamer 407 gels. Int. J. Pharm., 288, 235–244 (2005).
Ro, H. S., Kim, O. J., Park, K. K., Cho, T. H., and Park, H. S., Studies on diet regimens for the development of hyperlipidemic animal model. J. Kor. Pharm. Sci., 24, 297–321 (1994).
Ross, R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801–809 (1993).
Rota, S., McWilliam, N. A., Baglin, T. P., and Byrne, C. D., Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation modulation by oxidation and vitamin E. Blood, 91, 509–515 (1998).
Sanna, V., Kirschvink, N., Gustin, P., Garini, E., Roland, I., Delattre, L., and Evrard, B., Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS. Pharm. Sci. Tech., 5, e27 (2004).
Schaefer, E. J., Lichtenstein, A. H., Lamom-Fava, S., McNamara, J. R., and Ordovas, J. M., Lipoproteins, nutrition, aging, and atherosclerosis. Am. J. Clin. Nutr., 61, 726S–740S (1995).
Schmolka, I. R., Poloxamers in the pharmaceutical industry. In: Tarch, P. J. (Ed.). Polymers for controlled drug delivery. CSC Press, Boca Raton, pp. 189–215 (1991).
Sliskovic, D. R., and White, A. D., Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents. Trends Pharmacol. Sci., 12, 194–199 (1991).
Szilvassy, Z., Csont, T., Pali, T., Droy-lefaix, M. T., and Ferdinandy, P., Nitric oxide, peroxinitrite and cGMP in atheroscleosis-induced hypertention in rabbits: beneficial effects of cicleranine. J. Vasc. Res., 38, 39–46 (2001).
Talbert, R., Hyperlipidemia, DePiro Textbook of Threrapeytics. Appleton and Lange, Connecticut, pp. 357–386 (1997).
Taniguchi, K., Kurata, K., and Suzuki, M., Feeding-deterrent effect of phlorotannins from the brown alga Ecklonia stolonifera against the abalone Haliotis discushannai. Nippon Suisan Gakkaishi, 57, 2065–2071 (1991).
Wald, N. J. and Law, M. R., Serum cholesterol and ischemic heart disease. Atherosclerosis, 118, S1–S5 (1995).
White, C. R., Brock, T. A., Chang, L. Y., Crapo, J., Briscoe, P., Ku, D., Bardley, W. A., Gianturco, S. H., Gore, J., Freeman, B. A., and Tarpey, M. M., Superoxide and peroxinitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA, 91, 1044–1048 (1994).
Wout, Z. G., Pec E. A., and Maggiore, J. A., Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats. J. Parenter. Sci. Technol., 46, 192–200 (1992).
Yamada, K., Tokunaga, Y., Ikeda, A., Ohkura, K., Kaku-Ohkura, S., Mamiya, S., Lim, B. O., and Tachibana, H., Effect of dietary fiber on the lipid metabolism and immune function of aged Sprague-Dawley rats. Biosci. Biotechnol. Biochem., 67, 429–433 (2003).
Yasuda, S., Townsend, D., Michele, D. E., Favre, E. G., Day, S. M., and Metzger, J. M., Dystrophic heart failure blocked by membrane sealant poloxamer. Nature, 436, 1025–1029 (2005).
Yokozawa, T., Cho, E. J., Sasaki, S., Satoh, A., Okamato, T., and Sei, Y., The protective role of Chinese prescription kangen-karyu extract on diet-induced hypercholesterolemia in rats. Biol. Pharm. Bull., 29, 760–765 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, N.Y., Kim, H.R., Chung, H.Y. et al. Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Arch. Pharm. Res. 31, 1564–1571 (2008). https://doi.org/10.1007/s12272-001-2152-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-2152-8